PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+20.77%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$707M
AUM Growth
+$707M
(+30%)
Cap. Flow
+$87.9M
Cap. Flow
% of AUM
12.44%
Top 10 Holdings %
Top 10 Hldgs %
36.4%
Holding
113
New
10
Increased
54
Reduced
24
Closed
24
Top Buys
| 1 |
Abbott
ABT
|
$17.3M |
| 2 |
Inspire Medical Systems
INSP
|
$15.6M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$13.3M |
| 4 |
Amgen
AMGN
|
$12M |
| 5 |
Syndax Pharmaceuticals
SNDX
|
$11.4M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
$13.8M |
| 2 |
IMGN
Immunogen Inc
IMGN
|
$11.4M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$8.68M |
| 4 |
Charles River Laboratories
CRL
|
$8.65M |
| 5 |
Zimmer Biomet
ZBH
|
$7.97M |
Sector Composition
| 1 | Healthcare | 99.16% |
| 2 | Industrials | 0.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Pacific Biosciences
PACB
$384M
| – | – |
-210,580
| Closed | -$1.76M |
|
102
Soleno Therapeutics
SLNO
$3.5B
| – | – |
-100,000
| Closed | -$2.95M |
|
103
Terns Pharmaceuticals
TERN
$636M
| – | – |
-41,728
| Closed | -$210K |
|
104
Voyager Therapeutics
VYGR
$206M
| – | – |
-60,322
| Closed | -$467K |
|
|
105
Zimmer Biomet
ZBH
$20.8B
| – | – |
-71,000
| Closed | -$7.97M |
|
|
CUTR
106
DELISTED
Cutera, Inc.
CUTR
| – | – |
-100,000
| Closed | -$602K |
|
|
CDMO
107
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| – | – |
-185,613
| Closed | -$1.75M |
|
|
CTLT
108
DELISTED
CATALENT, INC.
CTLT
| – | – |
-80,646
| Closed | -$3.67M |
|
|
MORF
109
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| – | – |
-75,000
| Closed | -$1.72M |
|
|
AFIB
110
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
| – | – |
-794,145
| Closed | -$553K |
|
|
KRTX
111
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| – | – |
-51,311
| Closed | -$8.68M |
|
|
IMGN
112
DELISTED
Immunogen Inc
IMGN
| – | – |
-717,920
| Closed | -$11.4M |
|
113
Acadia Pharmaceuticals
ACAD
$4.31B
| – | – |
-115,777
| Closed | -$2.41M |
|